What is Pro Medicus Limited (PMCUF)?

Pro Medicus Limited (PMCUF) is a stock in the Healthcare sector, Medical - Healthcare Information Services industry. View full analysis on Stocks360.

What is the current price of PMCUF?

The current price of PMCUF is $132.14. Prices are updated in real time on Stocks360.

What is PMCUF's price-to-earnings (PE) ratio?

PMCUF's trailing twelve-month PE ratio is 77.24, based on current price and earnings per share data available on Stocks360.

What is PMCUF's market capitalization?

PMCUF's market capitalization is $13,804,660,911.00, placing it in the large-cap tier.

Does PMCUF pay a dividend?

Yes. PMCUF has a trailing twelve-month dividend yield of 0.00%. Dividend data is sourced from financial market providers and displayed on Stocks360.

Pro Medicus Limited (PMCUF)

Stock analysis · OTC · Healthcare · Medical - Healthcare Information Services

$132.14

Market Cap

$13.80B

PE (TTM)

77.24

EPS (TTM)

N/A

Dividend Yield

0.35%

Beta

0.57

Day Range

$132.14 – $132.14

52-wk Range

$74.52 – $180.00

Avg Volume

N/A

Volume

62.00

Pro Medicus Limited (PMCUF) is a publicly traded company in the Healthcare sector. Latest price: $132.14. Market cap $13.80B. Trailing PE 77.24. Dividend yield 0.35%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 4 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-31 · $163.88 2026-10-30 · $132.14 (-19.37%)

Earnings

Most Recent

Aug 17, 2026

EPS $0.51 vs est. $0.48

Beat by $0.03

Next Earnings

Feb 16, 2027

EPS estimate $0.59

Proprietary Signals

Signal snapshot temporarily unavailable.

About Pro Medicus Limited

Based in Richmond, Australia, and established in 1983, Pro Medicus Limited is a leading developer and provider of cutting-edge healthcare imaging software and support services. The company caters to a diverse range of medical institutions, including hospitals and diagnostic imaging facilities, across Australia, North America, and Europe. Its comprehensive product suite features a proprietary Radiology Information System (RIS), designed for efficient practice management, which comes complete with training, installation, professional services, and ongoing post-sales support (marketed under names like Visage RIS). Additionally, Pro Medicus offers Promedicus.net, an e-health platform, and advanced healthcare imaging software that empowers radiologists and clinicians with robust visualization capabilities for 2D, 3D, and 4D medical images, alongside its Picture Archiving and Communication System (PACS)/digital imaging solutions (e.g., Visage 7). The company also provides integration products and the Visage Ease Pro mobile application, allowing users to remotely interpret diagnostic imaging studies stored on a Visage 7 server.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	77.24×
P/S (TTM)	78.33×
P/B	45.46×
PEG	0.60×
P/FCF (TTM)	172.54×
EV / EBITDA	99.68×
EV / Sales	77.77×
Earnings Yield	1.29%
Free Cash Flow Yield	0.58%
Dividend Yield	0.35%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$20.35B
Revenue (TTM)	$261.69M
Net Income (TTM)	$265.34M
Free Cash Flow (TTM)	$127.04M
Net Debt	-$144.25M
Working Capital	$303.85M
Gross Margin	80.69%
Operating Margin	74.94%
Net Margin	101.40%
Return on Equity	63.19%
Return on Invested Capital	24.67%